Clonorchiasis Market Shares, Revenue, Top most Industry Compotators by 2023

Market Highlights

Increasing prevalence of clonorchiasis, changing lifestyle, poor diet, and increasing geriatric population have driven the growth of the market. Moreover, increasing healthcare expenditure has fuelled the growth of the market. On the other hand, high cost of the treatment may slow the market growth.

Clonorchiasis is an infectious disease caused by the Chinese liver fluke Clonorchis sinensis. Clonorchiasis is dominant in Asian countries and regions, including South Korea, China, Northern Vietnam, and far-eastern Russia. China has the largest population of infected people. In the acute phase, heavier infections can cause fever, chills, epigastric pain, tender hepatomegaly, mild jaundice, and eosinophilia occur. Chronic cholangitis in heavy infections, which may progress to atrophy of liver parenchyma, portal fibrosis, and cirrhosis.

The global clonorchiasis market is expected to grow at a CAGR of 5.4% during the forecast period.

Segmentation

The global clonorchiasis market is segmented on the basis of parasites, therapy, and end users.

On the basis of the parasites, the market is segmented into Clonorchis sinensis, Opisthorchis viverrini, Opisthorchis felineus, and others.

On the basis of the therapy, the market is segmented into diagnosis and treatment. The diagnosis is further segmented into microscopic examination, X-ray, serologic tests, and others. The treatment is sub-segmented into praziquantel, cesol, cisticid, biltricide, and others.

On the basis of end users, the market is segmented into hospital, clinics, and others.

 Key Players

The key players for the global clonorchiasis market are Pfizer (U.S), Bayer AG (Germany), Provet (Switzerland), Virbac (India), Cipla (India), Novartis AG (Switzerland), CIRON Drugs & Pharmaceuticals Pvt. Ltd. (India), Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott (U.S.), Arsanis, Inc. (Austria), Novabiotics (U.K.), GlaxoSmithKline plc. (U.K.), and Teva Pharmaceutical Industries Ltd (Taiwan). 

Article source: https://article-realm.com/article/Sports-Recreation/12743-Clonorchiasis-Market-Shares-Revenue-Top-most-Industry-Compotators-by-2023.html